03/26/2024 7:22 PM | Cumberland Pharmaceuticals (Issuer) Hamm John M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 7:24 PM | Anthony Todd M. (Reporting) Cumberland Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 7:25 PM | Bitterman Chris T. (Reporting) Cumberland Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 7:26 PM | Cumberland Pharmaceuticals (Issuer) Herman James L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 7:28 PM | Cumberland Pharmaceuticals (Issuer) KAZIMI A J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 7:29 PM | Brown Martin S JR (Reporting) Cumberland Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 7:31 PM | Cumberland Pharmaceuticals (Issuer) Young Caroline (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/26/2024 7:31 PM | Cumberland Pharmaceuticals (Issuer) Galante Joseph C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 7:32 PM | Cumberland Pharmaceuticals (Issuer) Jones James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 7:33 PM | Cumberland Pharmaceuticals (Issuer) Krogulski Kenneth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:15 PM | Cumberland Pharmaceuticals (Filer)
| Form 424B5 | |
03/20/2024 4:20 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 4:03 PM | Cumberland Pharmaceuticals (Filer)
| Form DEF 14A | |
03/13/2024 4:04 PM | Cumberland Pharmaceuticals (Filer)
| Form DEFA14A | |
03/05/2024 4:10 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/09/2024 4:27 PM | Cumberland Pharmaceuticals (Subject)
| Form SC 13G | |
12/28/2023 4:07 PM | Cumberland Pharmaceuticals (Issuer) KAZIMI A J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 4:08 PM | Cumberland Pharmaceuticals (Issuer) Krogulski Kenneth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 4:10 PM | Cumberland Pharmaceuticals (Issuer) Young Caroline (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 4:11 PM | Cumberland Pharmaceuticals (Issuer) Jones James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 11:15 PM | Cumberland Pharmaceuticals (Filer)
| Form EFFECT | |
12/14/2023 4:09 PM | Cumberland Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
12/06/2023 4:01 PM | Cumberland Pharmaceuticals (Issuer) Krogulski Kenneth (Reporting)
| Form 4/A | |
12/06/2023 4:02 PM | Cumberland Pharmaceuticals (Issuer) KAZIMI A J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 4:03 PM | Cumberland Pharmaceuticals (Issuer) Jones James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 4:04 PM | Cumberland Pharmaceuticals (Issuer) Young Caroline (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 4:05 PM | Cumberland Pharmaceuticals (Issuer) Hamm John M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 7:15 AM | Cumberland Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023 4:21 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2023 4:04 PM | Cumberland Pharmaceuticals (Issuer) Krogulski Kenneth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2023 8:11 AM | Cumberland Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/19/2023 8:24 AM | Cumberland Pharmaceuticals (Issuer) Krogulski Kenneth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 4:04 PM | Cumberland Pharmaceuticals (Issuer) Jones James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 4:04 PM | Cumberland Pharmaceuticals (Issuer) Krogulski Kenneth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/11/2023 4:05 PM | Cumberland Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023 4:23 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/30/2023 4:20 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2023 4:01 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2023 4:18 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |